Takeda acquires investigational coeliac therapy
The Japanese pharma giant acquired the drug based on results from a phase IIa trial, in which the drug met its primary endpoint.
Read More
Tag: gluten
Coeliac UK, Innovate UK announce £180K research funding available
Criteria for the projects must underpin and support Coeliac UK’s top ten research priorities.
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
